A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT02368314

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
  • Biocad Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02368314
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02368314. Randomized; triple masking; primary purpose prevention. Start 2015-01 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2016-10-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries
Intervention (Drug)
Sodium Enoxaparine
Lead sponsor
Biocad (class: industry)

Record details

Record id
cardio:ct-nct02368314
Content hash
9ab073f15b09f0e00fd6254b96b84b5f34d28335fc540ace8e4853f9e8fb0c6e